The serum sialic acid (SA) concentration has been reported to be a potentially useful but nonspecific disease marker. We wanted to study which factors influence SA concentration in a well-characterized healthy population. Methods: SA was determined in 97 women and 96 men with a colorimetric Warren method. Results: The mean ؎ SD concentrations of SA were 634 ؎ 109 (95% confidence interval, 612-656) and 630 ؎ 106 (95% confidence interval, 608 -651) mg/L for women and men, respectively. The serum SA showed a significant positive association with body mass index and with systolic and diastolic blood pressure among both women and men. SA also correlated significantly with the use of contraceptive pills and age among women and with smoking among men. Conclusions: Our study suggests that SA does not increase with age in men but appears to increase with female menopause. The strong positive association with blood pressure may explain why SA predicts cardiovascular mortality.
The suggested biological functions of SA include: (a) stabilizing the conformation of glycoproteins and cellular membranes; (b) assisting in cell to cell recognition and interaction; (c) contributing to membrane transport; (d) affecting the function of membrane receptors by providing binding sites for ligands; (e) influencing the function, stability, and survival of blood glycoproteins; and ( f) regulating the permeability of the basement membrane of glomeruli (1 ) .
Increased SA concentrations have been observed in several diseases, e.g., tumors, myocardial infarction, diabetes, inflammatory disorders, and alcoholism (2) (3) (4) (5) (6) (7) (8) . The clinical usefulness of serum SA determination in inherited SA storage diseases is well established. Serum SA is also increased during inflammatory processes because of increased concentrations of richly sialylated acute phase glycoproteins. There are data suggesting a positive relationship between serum SA and stroke and cardiovascular mortality (9 ) . Cancer patients have increased SA concentrations, which correlate positively with the degree of metastasis and are useful in monitoring treatment (2 ) . Thus, several different mechanisms may lead to increased SA concentrations in various pathological conditions. The nonspecificity of serum SA limits its clinical usefulness. Nevertheless, when combined with other markers, SA concentrations are helpful in disease screening and follow-up, as well as in monitoring of treatment.
The aim of the present work was to determine reference values for serum SA in women and men among a wellcharacterized healthy population. We also assessed the effect of age, body mass index (BMI), blood pressure, smoking, and hormonal disturbances on serum SA concentrations. There are different methods for measuring SA: colorimetric, enzymatic, fluorescence, and chromatographic (2, 10, 11 ) . We used a slightly modified version of the colorimetric thiobarbiturate assay by Warren (12 ) .
Materials and Methods study population
The present study population is part of a national health program conducted and coordinated by the National Public Health Institute of Finland (KTL). The study was conducted according to the Helsinki Declaration of Human Experimentation, and it was approved by the Ethical Committee of Primary Health Clinics in Finland.
The study was conducted in five geographic areas in Finland at the beginning of 1997. The total study population consisted of 11 500 subjects. The survey included a self-administrated questionnaire with 156 questions about health-related factors and socioeconomic background. The subpopulation for the present study was selected using the following exclusion criteria: (a) alcohol consumption during the week before entering the study of Ͼ105 g ethanol or an average weekly alcohol consumption during the past year of Ͼ105 g ethanol; (b) being drunk more than once a month during the last year; (c) pregnancy; (d) cerebrovascular disease; (e) coronary heart disease or cardiac insufficiency; ( f ) cancer; (g) lung emphysema; (h) biliary calculi or infection; (i) rheumatoid arthritis; ( j) kidney or urinary tract disease; (k) diabetes; and (l) use of the following medications during the past month before entering the study: sleeping pills, sedatives, antidepressants, or anticoagulants. The average alcohol consumption was calculated assuming that beer, long drinks, spirits, and wine contained 12 g of alcohol per serving, and cider and low alcoholic wine have 4 g. For the present study, 100 men and 100 women were randomly selected from the larger population after implementing the exclusion criteria so that each of the five age groups (18 -30, 31-40, 41-50, 51-60, and 61-75) had an equal number of subjects, divided equally between both genders. Sera from 97 women and 96 men were available for the study. The sera were stored at Ϫ70°C until use.
questionnaire and clinical measurements
Every patient answered a questionnaire on social and behavioral factors (e.g., age, occupation, education, smoking status, and drinking) and somatic diseases. Blood pressure was measured after 15 min of rest in a sitting position from the right arm of the subject by trained nurses using standardized Hg manometers. The pressure was recorded twice, and the second value was used in the present analysis. Subjects were fasting 4 h before sample collection.
biochemical analysis
Serum SA was measured with a slightly modified version of the method of Warren (12 ) . In comparison to the original Warren method, smaller volumes of samples and reagents were used, and photometry was carried out at ϭ 549 and 513 nm, instead of 549 and 532 nm. The modified Warren method used was performed as follows. Known concentrations of N-acetylneuraminic acid were diluted in redistilled water. The sample (100 L) was hydrolyzed with 10 L of 1.5 mol/L sulfuric acid, mixed, and incubated for 60 min at 80°C. The tubes were cooled to room temperature in tap water. Subsequently, 50 L of 0.2 mol/L sodium metaperiodate was added in 10.5 mol/L 85% orthophosphoric acid. The tubes were mixed and incubated for 20 min at room temperature. Next, 500 L of 0.77 mol/L sodium meta-arsenite was added in 56 mmol/L sulfuric acid, and the tubes were mixed until the the yellow-brown color disappeared. Then, 1.5 mL of 42 mmol/L thiobarbituric acid in 506 mmol/L sodium sulfate was added, and the tubes were incubated in a boiling water bath for 15 min and then cooled to room temperature in tap water. Next, 2 mL of cyclohexanone was added. The tubes were mixed vigorously and centrifuged for 3 min at 500g. The supernatant was transferred into new tubes, and the absorbance was read at 549 and 513 nm. The difference between A 549 and A 513 was calculated, and the sample concentration was read from the calibration curve. The measuring range used was 5-125 mg/L of N-acetylneuraminic acid. Carbohydrate-deficient transferrin (CDT) was determined by a double antibody kit, CDTect RIA (Pharmacia & Upjohn AB, Diagnostics, Uppsala, Sweden) according to the manufacturer's instructions. Serum ␥-glutamyltransferase (GGT) was assayed by a routine clinical laboratory method. Serum SA was analyzed in duplicates, and CDT and GGT were analyzed as single replicates.
statistical methods
The relationships between continuous variables were studied using standard regression and correlation methods. Relationships between SA and classification variables or combinations of classification variables with continu- ous variables were modeled as general linear models (13 ) . SAS (1989) software was used for all analyses and graphs (14 ) . Mean values for groups, adjusted for the effects of other variables, were calculated as least squares means using the GLM procedure of the SAS (1991) package (13 ) .
Piecewise regression models (15 ) were used to study how SA may depend on age. The model y ϭ ␣ ϩ ␤x ϩ ␥d(x Ϫ x 0 ) ϩ ⑀ was fitted to the data using an iterative algorithm where all parameters are simultaneously estimated. Here, x is age and y is the logarithm of the SA concentration. This model implies that there is a linear relationship between x and y but that different lines are used before and after some changepoint x 0 , which is also estimated. If the estimate of the parameter ␥ is not significant, there would be no indication of a firm "age of change"; otherwise, x 0 is interpreted as the age at which there is a change in the relationship between x and y.
Results

descriptive statistics of serum sa
The mean Ϯ SD concentrations of SA were 634 Ϯ 109 mg/L (95% confidence interval, 612-656 mg/L) in women and 630 Ϯ 106 (95% confidence interval, 608 -651) mg/L in men. The 90% and 95% quantiles were 764 and 835 mg/L for women, and 767 and 809 mg/L for men. Serum SA concentration was slightly skewed to the right for both sexes. Therefore, the natural logarithm (ln) of SA concentration was also used in the regression analysis.
association of serum sa with age Table 1 shows the age dependency of serum SA, systolic blood pressure, diastolic blood pressure, and BMI. In Fig.  1 , a piecewise regression analysis of SA with age is shown. It appears that the mean serum concentrations of SA start to increase in women at about 45 years of age, which is close to the mean age of menopause (Figs. 1A and 2A; Table 1 ). The break in the line is statistically significant (P Ͻ0.05). In men, no statistically significant increase of SA with age was observed, nor was there any detectable "age of change" (Figs. 1B and 2B; Table 1 ). Systolic and diastolic blood pressure increased significantly with age in both genders.
univariate analysis of serum sa with other variables
Univariate regression analysis was performed with SA as the dependent variable. There was no essential difference in the main results when lnSA was used instead of SA as the dependent variable. SA concentrations correlated positively with age in women (r ϭ 0.28, P Ͻ0.01) but not in men. SA correlated significantly with BMI (women: r ϭ 0.38, P Ͻ0.001; men: r ϭ 0.22, P Ͻ0.05), with systolic blood pressure (women: r ϭ 0.48, P Ͻ0.001; men: r ϭ 0.25, P Ͻ0.05), and with diastolic blood pressure (women: r ϭ 0.43, P Ͻ0.001; men: r ϭ 0.26, P Ͻ0.05; Fig. 3 ). SA and smoking showed a significant correlation in male subjects (r ϭ 0.24, P Ͻ0.05) but not in females; in men, this trend was also seen when the number of cigarettes per day (r ϭ 0.18, P ϭ 0.09) was used as the independent variable. The age-and BMI-adjusted SA concentrations of male smokers were significantly (P Ͻ0.05) higher than those of nonsmokers. Mean alcohol consumption last week and year, GGT, and CDT did not correlate significantly with SA.
multiple linear regression analysis of serum sa and associated variables A stepwise regression analysis was done with serum SA as the dependent variable and the following independent variables: age, smoking, BMI, systolic blood pressure, diastolic blood pressure, and mean alcohol consumption during the last week and last year.
In women, when SA was adjusted for age and BMI, it correlated with systolic (P Ͻ0.01) and diastolic (P Ͻ0.05) blood pressure and with mean blood pressure (P Ͻ0.001). The corresponding analysis for male subjects showed a correlation with systolic blood pressure (P Ͻ0.05) and mean blood pressure (P Ͻ0.05) but not with diastolic blood pressure.
association of serum sa with hormones in women Table 2 summarizes the results concerning hormonal factors. The serum SA concentrations were adjusted for age and BMI. Serum SA concentrations were increased by the use of contraceptive pills (P Ͻ0.05) and hormone treatment (P Ͻ0.05).
Discussion
Our reference material consisted of a randomly selected sample of the general population. Our primary goal was to determine the reference serum SA concentrations for women and men. We also studied the effect of age, BMI, blood pressure, smoking, and hormonal factors on serum SA.
The mean serum SA concentrations did not differ between female and male subjects, and they were in the range of 0.52-0.73 g/L, which is in accordance with earlier findings (2 ) . The SA concentration was somewhat skewed to the right, as also reported previously by Lindberg et al. (16 ) .
We show that the serum total SA concentration increases with age in women but not in men. The reason for the increase among women seems to be menopause. This is at variance with some earlier studies, which have shown an increase of serum SA for both women and men and no effect of menopause (16 -18 ) . On the other hand, there are also studies where serum SA concentrations were not correlated with age for either sex (19 -21 ) . Because several diseases are known to increase serum SA concentrations (2 ), one explanation for the increase of serum SA with age would be a higher frequency of subclinically diseased individuals among the elderly. Several SA-containing acute phase reactants also increase with age, e.g., fibrinogen, C-reactive protein, ␣ 1 -acid glycoprotein, ␣ 1 -antichymotrypsin, ␣ 1 -antitrypsin, and haptoglobulin (22, 23 ) . Serum SA concentrations and BMI showed a positive relationship. Other studies have also shown a similar association (16, 24, 25 ) . The fact that BMI is known to be associated with several other factors, including blood pressure, underlines the importance of taking it into consideration when assessing the independent importance of SA on the other factors. We also found that smoking increased the serum SA concentration in men but not in women. This is in accordance with a previous study where young male smokers had increased SA concentrations, but the increase was not seen in women (17 ) . There is no apparent explanation for why smoking increases serum SA in men but not in women.
In the present study, we made the primary observation that in otherwise healthy men and women, serum SA correlated positively with blood pressure, even after adjusting for age and BMI. A recent study of a smaller healthy population of men and women (n ϭ 46 and n ϭ 54, respectively) has also reported an independent correlation of serum total SA with systolic and diastolic blood pressure, but only in women (26 ) . In contrast, in male and female diabetic subjects, there was no independent association of serum SA with mean blood pressure (24 ) . Blood pressure is considered an important cardiovascular risk factor. The finding that blood pressure correlates positively with serum SA may explain in part why SA predicts cardiovascular mortality (9, 16 ) . Other cardiovascular risk factors are also known to be reflected in serum SA concentration, such as the SA-containing acute phase protein fibrinogen (27 ) . In fact, there is a general chronic inflammatory process involving many acute phase proteins in atherosclerosis (28 ) . Moreover, both SA and the risk of coronary heart disease increase after menopause (29 ) .
In conclusion, this study demonstrates that blood pressure and serum SA are associated in both women and men independently of age and BMI. This implicates one mechanism behind the earlier observation about the association between SA and cardiovascular risk. A possible explanation of these findings is that serum SA reflects acceleration of the atherosclerotic process by increased blood pressure, which is a known independent risk factor for atheroslerosis. In women, age and the use of contraceptive pills are factors increasing serum SA. In men, smoking increases serum SA. The biological mechanism(s) causing increased serum SA in various diseases, including cardiovascular disease, are far from clear. The above-mentioned factors should be taken into consideration when choosing control groups for clinical studies where serum SA is analyzed. Furthermore, because contraceptives, smoking, BMI, and other factors, including menopause, increase SA, it is difficult to give reference values of serum SA separately for different age groups. On the other hand, the present study supports the conclusion that SA is relatively stable among men 25-64 years of age and among women 25-54 years of age.
